Published in Proc Soc Exp Biol Med on March 01, 1983
Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization. Acta Neuropathol (1987) 0.91
Oral antiviral drugs in experimental herpes simplex keratitis. Antimicrob Agents Chemother (1983) 0.86
Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits. Antimicrob Agents Chemother (2001) 0.81
Production and characterization of an anti-idiotypic antibody specific for a monoclonal antibody to glycoprotein D of herpes simplex virus. Immunology (1986) 0.78
Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol (1987) 5.45
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 3.51
Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J Virol (1988) 3.51
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol (1986) 3.31
Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nat New Biol (1972) 3.23
The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol (1994) 2.94
Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J Virol (1990) 2.87
Bilateral photorefractive keratectomy with intentional unilateral undercorrection in an aircraft pilot. J Cataract Refract Surg (1997) 2.59
Videokeratography of the fellow eye in unilateral keratoconus. Ophthalmology (1993) 2.46
Sequence of the latency-related gene of herpes simplex virus type 1. Virology (1989) 2.29
Isolation and characterization of a herpes-like virus from New Zealand albino rabbit kidney cell cultures: a probable reisolation of virus 3 of Rivers. J Virol (1969) 2.20
Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol (1979) 1.94
The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J Virol (1996) 1.93
Excimer laser ablation of the human lens at 308 nm with a fiber delivery system. J Cataract Refract Surg (1989) 1.92
Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J Gen Virol (1988) 1.89
Architecture of the Adenovirus Capsid. J Bacteriol (1965) 1.75
Spontaneous reactivation of experimental herpes simplex keratitis in rabbits. Arch Ophthalmol (1967) 1.61
The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J Virol (2000) 1.57
Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture. J Virol (2001) 1.55
An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J Virol (1995) 1.54
In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1. J Gen Virol (1989) 1.52
A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J Virol (1996) 1.51
Photorefractive keratectomy for low-to-moderate myopia and astigmatism with a small-beam, tracker-directed excimer laser. Ophthalmology (1999) 1.49
Identification of a major regulatory sequence in the latency associated transcript (LAT) promoter of herpes simplex virus type 1 (HSV-1). Virology (1991) 1.48
Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. Arch Ophthalmol (1972) 1.48
Complications associated with therapeutic soft contact lenses. Ophthalmology (1979) 1.39
A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation. J Virol (1999) 1.35
Abnormalities of the extracellular matrix in keratoconus corneas. Cornea (1997) 1.35
Demonstration of herpes group virus in acute retinal necrosis syndrome. Am J Ophthalmol (1986) 1.33
Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest (1992) 1.29
Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest Ophthalmol Vis Sci (1984) 1.27
Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol (1978) 1.27
Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc Natl Acad Sci U S A (1987) 1.26
The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J Virol (1996) 1.25
Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol (1994) 1.23
Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci (1996) 1.21
Penetrating keratoplasty: changing indications, 1947 to 1978. Arch Ophthalmol (1980) 1.20
Adenine arabinoside effect on experimental idoxuridine-resistant herpes simplex infection. Invest Ophthalmol (1974) 1.20
Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem (1996) 1.19
Experimental reactivation of ocular herpes simplex in rabbits. Surv Ophthalmol (1976) 1.19
Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb Pathog (1987) 1.18
The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependent. J Gen Virol (2001) 1.17
The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology (1998) 1.16
The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol (1989) 1.13
Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br J Ophthalmol (2000) 1.12
The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res (2000) 1.11
Isolation of Coxsackievirus B3 temperture-sensitive mutants and their assignment to complementation groups. Biochem Biophys Res Commun (1976) 1.11
Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest Ophthalmol Vis Sci (1995) 1.10
An improved method for cloning portions of the repeat regions of herpes simplex virus type 1. J Virol Methods (1994) 1.10
Detection of herpes simplex virus DNA sequences in corneal transplant recipients by polymerase chain reaction assays. Curr Eye Res (1991) 1.10
Cytomegaloviruses as common adventitious contaminants in primary African green monkey kidney cell cultures. J Natl Cancer Inst (1969) 1.09
Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits. J Virol (2001) 1.09
Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit. Invest Ophthalmol Vis Sci (1980) 1.08
Inhibition of herpes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate. Antiviral Res (1999) 1.07
Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D. Arch Virol (1991) 1.07
Cell surface expression of herpes simplex virus type 1 glycoprotein H in recombinant baculovirus-infected cells. Virology (1991) 1.07
Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology (1992) 1.07
Mapping herpes simplex virus type 1 latency-associated transcript sequences that protect from apoptosis mediated by a plasmid expressing caspase-8. J Neurovirol (2004) 1.06
Enhanced HSV recovery from neuronal tissues of latently infected rabbit. Proc Soc Exp Biol Med (1980) 1.05
Optisol corneal storage medium. Am J Ophthalmol (1992) 1.05
Interaction of immune and central nervous systems: contribution of anti-viral Thy-1+ cells to demyelination induced by coronavirus JHM. Reg Immunol (1993) 1.04
Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect Immun (1979) 1.02
Expression of the first 811 nucleotides of the herpes simplex virus type 1 latency-associated transcript (LAT) partially restores wild-type spontaneous reactivation to a LAT-null mutant. Virology (1999) 1.02
Varicella dendritic keratitis. Invest Ophthalmol (1974) 1.02
A two-year experience with excimer laser photorefractive keratectomy for myopia. Ophthalmology (1993) 1.01
Lack of hydrophilic lens discoloration in patients using dipivalyl epinephrine for glaucoma. Am J Ophthalmol (1979) 1.01
A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice. J Gen Virol (1988) 1.01
The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease. J Infect Dis (1999) 1.01
Bacteriophages and endotoxin in licensed live-virus vaccines. J Infect Dis (1975) 1.00
Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge. Virology (1992) 1.00
Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res (1996) 0.99
Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties. Virus Res (1992) 0.99
Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res (1995) 0.99
Simian hemorrhagic fever virus: a new togavirus. Proc Soc Exp Biol Med (1975) 0.98
The effect of trigeminal nerve and ganglion manipulation on recurrence of ocular herpes simplex in rabbits. Invest Ophthalmol (1976) 0.98
In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones. Cornea (2001) 0.97
Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J Infect Dis (1976) 0.97
Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes. Antimicrob Agents Chemother (1983) 0.97
Results of excimer laser photorefractive keratectomy for the correction of myopia. Ophthalmology (1994) 0.96
Extracellular matrix changes in human corneas after radial keratotomy. Exp Eye Res (1998) 0.95
Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice. J Virol (2001) 0.95
Immunostimulating polysaccharides from Panax notoginseng. Pharm Res (1996) 0.95
Evaluation of the antiherpetic activity of 2'-fluoro-5-iodo-ara-C in rabbit eyes and cell cultures. Invest Ophthalmol Vis Sci (1981) 0.95
Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun (1983) 0.94
Lack of toxicity of a topical recombinant interferon alpha. Cornea (1989) 0.93
Autoimmune dacryoadenitis and keratoconjunctivitis induced in rabbits by subcutaneous injection of autologous lymphocytes activated ex vivo against lacrimal antigens. J Autoimmun (2008) 0.93
Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K. J Virol (1994) 0.93
Assessment of acyclovir on acute ocular infection induced by drug-resistant strains of HSV-1. Invest Ophthalmol Vis Sci (1981) 0.92
The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology (1998) 0.92
Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes. J Virol (1999) 0.91